Searched for
GOOD IMMUNOGENIC RESPONSES
CEPI to fund Gennova's self amplifying mRNA vaccine against Disease XThe Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop...- How not to become China: Wastewater sampling — best strategy for a Covid-fatigued nationThe need of the hour is a dynamic, evidence-based approach, with involvement of public health experts and epidemiologists as guides, and to...
- Namma Homeopathy clinic gains popularity in Maharashtra and Karnataka due to its effective treatmentHomeopathy is a proven and effective method of medicine to fight diseases and Namma Homeopathy clinic have shown effective treatment all ov...
- India-US healthcare collaboration in spotlight as India approves two more COVID-19 vaccinesTaranjit Singh Sandhu, India's Ambassador to the US, in a tweet described it as a model of India-US healthcare collaboration. "Models of wh...
- Booster dose of six Covid vaccines safe, increases immunity: Lancet studyProtection against COVID-19 infection wanes over time, which has driven consideration of boosters to protect the most vulnerable and lessen...
- HUL ties up with Centre for study on vaccine efficacyHindustan Unilever Ltd (HUL) has partnered the Indian government for an academic-based research study which will help understand the factor...
- 12-16 week gap between Covishield doses, no change for Bharat Biotech's CovaxinIn the last three months, this is the second time that the Covishield dosage intervals have been extended. In March the government decided ...
- New COVID vaccine shows 'strong immune response' in early UK trialsUK Health Secretary Matt Hancock said that the promising Phase I and II results mean that the Valneva vaccine, being developed at Livingsto...
- Covaxin safe, may be superior to similar vaccines: LancetIndia’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journ...
- COVID-19 recovered people showing faster antibody response to Covishield vaccine: StudyThe study on the immune response to Covishield was carried out by researchers from New Delhi's CSIR-Institute of Genomics and Integrative B...
- Medical experts back both Serum Institute and Bharat Biotech's vaccines in IndiaThe endorsement letter from 49 medical experts, led by AIIMS’ former director TD Dogra, comes after reports emerged that some healthcare wo...
- Group of experts slams critics of India's approval process for COVID vaccinesIn a statement signed by 45 medical professionals and scientists, the group expressed shock at the "irresponsible statements of vested inte...
- How SEC changed Covaxin stanceAt the Jan 2 meeting, the firm presented more data and notably “requested for consideration of their proposal in the wake of incidence of n...
- Covid vaccine drive from Jan 13; SII, Bharat Bio make peaceThe Co-WIN app announced by the government will be central to the registration process.
- During pandemic, vaccine’s restricted use considered based on safety, immunogenicity data: ICMR chiefDrugs Controller General of India (DCGI) had on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, an...
- People who are infected should also take vaccine: Bharat Biotech ChairmanBharat Biotech Chairman & MD Krishna Ella was speaking in a virtual session on 'Sero surveillance significance in immunogenicity and safety...
- Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists sayThe decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...
- Dr Reddy's partners with Department of Biotechnology for Sputnik V vaccine clinical trials in IndiaChairman of Dr Reddys Laboratories, Satish Reddy said, "We are pleased with the collaboration with BIRAC as an advisory partner for clinica...
- Double protection: Oxford University COVID-19 vaccine hopes rise with strong trial resultsThe vaccine, named ChAdOx1 nCoV-19, is based on a weakened version of the common cold that causes infections in chimpanzees. It also contai...
- Expect Covid vaccine human trial to be completed in 3 months: Zydus Cadila Chairman‘We did a detailed 28-day toxicity study in two different animal species’
Load More
